The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease

Biancardi, Ana Luiza; Zaltman, Cyrla; Troncoso, Leandro Lopes; Luiz, Ronir Raggio; Moraes, Haroldo Vieira de

doi:10.1093/ibd/izy159

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In agreement with our findings, Kang et al found that 18% of their SpA patients had high fecal calprotectin levels, but there was no relationship between fecal calprotectin levels and the presence of active uveitis or a history of uveitis (16) . Biancardi et al had the same findings while studying uveitis in inflammatory bowel disease (17) .…”

Section: Discussionmentioning

confidence: 62%

Fecal calprotectin levels in acute anterior uveitis in patients with spondyloarthritis

Gazim

Borba

Castro³

et al. 2023

ABO

View full text Add to dashboard Cite

This study measured fecal calprotectin levels in a series of patients with anterior uveitis in order to determine whether anterior uveitis patients with associated spondyloarthritis have higher levels of fecal calprotectin than patients with anterior uveitis of other etiologies. A third group of patients with spondyloarthritis without uveitis was also evaluated to understand the role of acute anterior uveitis in increasing fecal calprotectin. Methods: In this cross-sectional study, 28 patients were divided into three groups: (a) Group 1, spondyloarthritis and uveitis (n=9); (b) Group 2, spondyloarthritis without uveitis (n=10); and (c) Group 3, uveitis without spondyloarthritis (n=9). The levels of fecal calprotectin were determined. Results: Groups 1 and 2 showed higher median fecal calprotectin levels (101.0 and 93.0 µg/g, respectively) compared with Group 3 (9.0 µg/g) (p=0.02). However, no relationship between fecal calprotectin levels and the presence of uveitis with spondyloarthritis could be demonstrated. Conclusion: Patients with spondyloarthritis with or without acute anterior uveitis have significantly elevated levels of fecal calprotectin. This test may be useful for differentiating spondyloarthrit-associated uveitis from uveitis of other etiologies.

show abstract

Section: Discussionmentioning

confidence: 62%

Fecal calprotectin levels in acute anterior uveitis in patients with spondyloarthritis

Gazim

Borba

Castro³

et al. 2023

ABO

View full text Add to dashboard Cite

show abstract

“…The immune-mediated ophthalmic manifestations of IBD are characterized mainly by uveitis, episcleritis, and scleritis, and there are conflicting data regarding their relationships with clinical demographic characteristics [2,3]. The different methodologies, different populations studied, and different numbers of patients enrolled make the interpretation of these data challenging.…”

mentioning

confidence: 99%

The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease

et al. 2019

Self Cite

View full text Add to dashboard Cite

The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease

Cited by 2 publications

References 4 publications

Fecal calprotectin levels in acute anterior uveitis in patients with spondyloarthritis

Fecal calprotectin levels in acute anterior uveitis in patients with spondyloarthritis

The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease

Contact Info

Product

Resources

About